Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.
“This is the most common muscle disease in boys, and there is currently no effective therapy,” saidDongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. “This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease.”
Patients with Duchenne muscular dystrophy have a gene mutation that disrupts the production of a protein known as “dystrophin.” Absence of dystrophin starts a chain reaction that eventually leads to muscle cell degeneration and death. Affected boys lose their ability to walk and breathe as they get older. This places significant limitations on individuals afflicted with the disease. Dystrophin also is one of the largest genes in the human body.
“Due to its size, it is impossible to deliver the entire gene with a gene therapy vector, which is the vehicle that carries the therapeutic gene to the correct site in the body,” Duan said. “Through previous research, we were able to develop a miniature version of this gene called a microgene. This minimized dystrophin protected all muscles in the body of diseased mice.”
However, it took the team more than 10 years to develop a strategy that can safely send the micro-dystrophin to every muscle in a dog that is afflicted by the disease. The dog has a body size similar to that of an affected boy. Success in the dog will set the foundation for human tests.
In this latest study, the MU team demonstrated for the first time that a common virus can deliver the microgene to all muscles in the body of a diseased dog. The dogs were injected with the virus when they were two to three months old and just starting to show signs of DMD. The dogs are now six to seven months old and continue to develop normally.
“The virus we are using is one of the most common viruses; it is also a virus that produces no symptoms in the human body, making this a safe way to spread the dystrophin gene throughout the body,” Duan said. “These dogs develop DMD naturally in a similar manner as humans. It’s important to treat DMD early before the disease does a lot of damage as this therapy has the greatest impact at the early stages in life.”
The Latest on: Muscular Dystrophy
via Google News
The Latest on: Muscular Dystrophy
- UMass Medical School Works To Ease Challenge Of Duchenne Muscular Dystrophyon November 29, 2019 at 5:10 am
WORCESTER (CBS) — Caring for a child with Duchenne Muscular Dystrophy can be incredibly challenging, but thanks to a local family’s philanthropy and a local medical school’s commitment, treatment is ...
- Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2Aon November 27, 2019 at 11:14 am
1 Généthon INSERM, U951, INTEGRARE Research Unit, Evry F-91002, France. 2 University of Arizona, Tucson, AZ 85724-5217, USA. 3 Department of Medicine, Karolinska Institute, Stockholm SE-171 77, Sweden ...
- New hope for muscular dystrophy patientson November 22, 2019 at 6:34 pm
It increases the dependency level of a patient and reduces normal body movements. The Indian Muscular Dystrophy Rehabilitation Centre at Kothon village near Solan is now also providing hydrotherapy, ...
- Teacher Refuses To Let Muscular Dystrophy Slow Him Downon November 22, 2019 at 4:13 am
FRESNO, Calif. -- After being diagnosed with limb-girdle muscular dystrophy at the age of 16, Edison High School teacher Shue Vang has refused to let it slow him down. "As long as I'm still breathing ...
- Brothers urge rethink on muscular dystrophy machine fundingon November 21, 2019 at 9:19 pm
Two brothers with muscular dystrophy have criticised a healthcare group for no longer providing "vital" equipment to others with the condition. The Derby and Derbyshire Clinical Commissioning Group ...
- Hikers Carry Man With Muscular Dystrophy to the Top of Utah Mountainon November 20, 2019 at 9:10 am
The goal was to hike 5,800 feet up a mountain with a group of 33 people, and Shue Vang was determined to be one of them. As a teenager, Vang was diagnosed with muscular dystrophy. He is no longer able ...
- Santhera Announces Publication of Long-term Idebenone Data from SYROS Study in Duchenne Muscular Dystrophyon November 19, 2019 at 7:48 pm
Buyse, MD, PhD, Professor of Pediatrics and Child Neurology, University Hospitals Leuven (Leuven, Belgium). About Duchenne Muscular Dystrophy DMD is one of the most common and devastating types of ...
- How a Man With Muscular Dystrophy Climbed to a Mountaintopon November 19, 2019 at 5:12 pm
Shue Vang was so overwhelmed when he reached the peak of Angels Landing Hike in Utah that he was moved to tears.
- Press Release: Santhera Announces Publication of Long-term Idebenone Data from SYROS Study in Duchenne Muscular Dystrophyon November 18, 2019 at 10:03 pm
reduced from -5.9% 'Off-Idebenone' to -1.9% 'On-Idebenone'. -- The annual rate of decline in FVC%p and PEF%p remained stable year after year for the entire follow-up time of up to six years and was ...
- A distant dream for us with muscular dystrophyon November 17, 2019 at 11:56 pm
A scratch on skin, a hug to my son, combing my hair, raising up from my chair, lifting a glass to sip water/tea, a walk on road, wiping a tear from my eye, lighting a diya – all of this seems so ...
via Bing News